|
INTERPHEX 2013 Announces Conference Program
INTERPHEX 2013, to be held Apr. 23—25, 2013, at the Javits Center in New York, will highlight pharmaceutical regulation QA/QC, product development, facility, process design, manufacturing, packaging, and supply chain programs. More... |
|
|
Ablynx and Spirogen Collaborate on Novel Toxin-Nanobody Drug Conjugates
Belgium drug developer Ablynx and UK-based Spirogen have entered into a research collaboration to discover and develop novel anticancer drug conjugates combining Spirogen’s proprietary cytotoxic drugs, pyrrolobenzodiazepines (PBDs), and the company’s associated linker technology, with nanobodies generated using Ablynx’s proprietary technology platform. More... |
|
|
|
|
|
|
|
|
Agilent |
Together: It’s how we help Pharma Succeed
Agilent QC solutions help simplify complexities for highest reproducibility from lab to lab, around the world. The Agilent 1290 Infinity LC with ISET enables secure method transfer between different U/HPLC instruments, with one click. CrossLab Services can reduce downtime for all instruments, regardless of manufacturer. “Fast LC” column choices help you get the most from every instrument. See more at www.agilent.com/chem/togetherQC |
 |
|
|
Roquette Pharma |
Coating heat-sensitive products at ambient temperature
See how LYCOAT® / ReadiLYCOAT® can be applied to your heat-sensitive ingredients or dosage forms at the same time as keeping the coating process short and providing an inert coating of perfect quality. And that’s not all.... Read more |
 |
|
|
|
|
|
What do you think is the main challenge facing manufacturers seeking to launch a new biosimilar? |
|
Safety and interchangeability concerns |
36% |
|
|
Regulatory processes |
28% |
|
|
|
|
Legal challenges |
9% |
|
|
|
|
Complex manufacturing processes |
27% |
This week we would like to know...
How do you think the reputation of the pharmaceutical industry has changed in recent years?

|
|
|
Contact Us |
Click here to contact editorial.
Click here to contact sales. |
|